Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.
Am J Nucl Med Mol Imaging
; 3(1): 16-31, 2013.
Article
em En
| MEDLINE
| ID: mdl-23342298
2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG); 3'-[18F]Fluoro-3'-deoxythymidine ([18F]FLT); Squamous cell carcinoma of the head and neck (SCCHN); epidermal growth factor receptor (EGFR); positron emission tomography (PET); region of interest (ROI); standardize uptake values (SUV); volume of interest (VOI)
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article